Patents by Inventor Robb Lawrence

Robb Lawrence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190154648
    Abstract: The present application relates generally to novel pharmaceutical drug formulations comprising modified chemical compositions having reduced capacity for excipient mediated cross reactivity. Methods for their use and methods for identifying excipient related incompatibilities and/or adverse events are also disclosed.
    Type: Application
    Filed: July 19, 2017
    Publication date: May 23, 2019
    Inventors: Robb Lawrence, Robert E Bakin